O

Orbis Medicines

Biotech & Life Sciences · Copenhagen, Denmark · Founded 2021

Orbis Medicines is a biopharmaceutical company focused on the discovery and development of oral macrocycle drugs. The company has developed a technology platform that enables the design and synthesis of these complex molecules, which have the potential to address a wide range of diseases that are currently difficult to treat with conventional small molecule drugs or biologics. Orbis is using its platform to build a pipeline of oral macrocycle drug candidates for various therapeutic areas. The company's business model is to advance these candidates through preclinical and early clinical development, and then partner with larger pharmaceutical companies for late-stage development and commercialization. Orbis recently secured a significant Series A financing round, which will be used to advance its lead programs and further develop its technology platform. Keywords: oral macrocycles, drug discovery, biopharmaceutical, therapeutics, clinical development, financing, platform, pipeline, molecules, diseases